Background. Although Aeromonas species are known to cause bacteremia in patients with cirrhosis, less is known about spontaneous bacterial peritonitis (SBP) caused by Aeromonas species in these patients.
Aeromonas bacteremia in patients with cirrhosis or malignancy has been found to be associated with a higher mortality rate than bacteremia caused by other organisms [1] [2] [3] [4] [5] . Except for anecdotal reports, however, little is known about spontaneous bacterial peritonitis (SBP) caused by Aeromonas species in cirrhotic patients, although Aeromonas species have been suggested to cause peritonitis in cirrhotic patients [6] .
In the Republic of Korea, Aeromonas species are the third most common organisms causing SBP, which is a prevalent cause of mortality in patients with cirrhosis [7] . Although areas with a high incidence of chronic liver diseases and a temperate climate, such as Taiwan, may have a similar incidence of SBP due to Aeromonas species, the incidence and characteristics of the infection have yet to be determined in these areas [8] .
The clinically relevant Aeromonas species are uniformly resistant to penicillin and ampicillin and are often resistant to first-and second-generation cephalosporins; however, they have usually been invariably susceptible to third-generation cephalosporin, aztreonam, and carbapenem [9, 10] . Recently, clinical Aeromonas isolates have shown increasing resistance to third-generation cephalosporins [11] . Therefore, we performed a retrospective, matched case-control study to compare the demographic characteristics, clinical manifestations, and outcomes of SBP due to Aeromonas species with those of SBP caused by other organisms. We also assessed the antimicrobial susceptibility of isolates from patients with SBP due to Aeromonas species.
MATERIALS AND METHODS

Study populations.
This study was performed at Asan Medical Center, a 2200-bed tertiary care institution in Seoul, Republic of Korea. All patients with culture-proven SBP due to Aeromonas species from January 1997 through December 2006 were included as patients in the analysis. Patients were initially identified from the hospital's microbiology database, followed by a detailed review of each patient's medical records. For the purpose of comparison, 2 control subjects were selected for each patient; control subjects consisted of patients with SBP caused by organisms other than Aeromonas species and were matched with the patients for age ‫1ע(‬ year) and sex during the same period.
The study population consisted of the 2 following groups of patients with clinical manifestations of SBP (i.e., fever or abdominal pain): (1) a group with definite SBP, defined as those with SBP caused by 1 monobacteria (culture was positive for ascites, and the ascitic polymorphonuclear cell [PMN] count was 1250 cells/mm 3 ) or 2 monobacterial bacteriascites (culture was positive for ascites, and the ascitic PMN count was !250 cells/mm 3 ), and (2) a group with probable SBP, defined as patients with monobacteremic neutrocytic ascites (the PMN count was 1250 cells/mm 3 , culture was negative for ascites, and the blood culture results were positive without any other primary focus) [12, 13] . We excluded patients with suspected secondary peritonitis, defined as (1) isolation of 11 organism from ascites or (2) the presence of at least 2 of the following in ascitic fluid: glucose level !50 mg/mL, protein concentration 11 g/dL, and lactic dehydrogenase levels greater than normal serum levels [12] . Patients who were receiving peritoneal dialysis were also excluded from the study.
Clinical data. Demographic characteristics included age, sex, season (July-September), rural residence, nosocomial infection, etiology of cirrhosis, comorbid diseases, Child-Pugh (CP) class, and model for end-stage liver disease score [14] . Nosocomial infection was defined by a positive culture result for patients who had been hospitalized for у48 h [15] . If a patient had been transferred from another hospital, the total length of hospital stay was calculated from the date of the first hospital admission. Community-acquired infection was defined by a positive culture result for a sample obtained at the time of hospital admission or within 48 h after hospital admission. To exclude the influence of acute deterioration on CP class and model for end-stage liver disease score, we used the best clinical parameters and laboratory data obtained within 1 month of the initial insult of SBP.
Clinical manifestations included the presence of initial symptoms and insults. Initial symptoms included fever (temperature, 138ЊC), abdominal pain, and diarrhea (defined as 13 loose stools per day). Initial insults included variceal bleeding, septic shock, renal function impairment, and hepatic encephalopathy (grade, 12). Septic shock was defined as described elsewhere [16] . Renal function impairment was defined as an increase in serum creatinine concentration of 12.0 mg/dL, compared with baseline, or a decrease in urine output to !400 cc per day. The use of medicinal leeches or the presence of skin and soft-tissue infection was also assessed [3, 17] .
Other clinical parameters included appropriateness of initial antibiotic therapy, 3-day mortality, in-hospital mortality, and 30-day cumulative survival. Initial antimicrobial therapy was considered to be appropriate if the patient received at least 1 antimicrobial agent to which the causative organism was demonstrated to be susceptible within 24 h of acquisition of the culture sample [18] .
Microbiology. Blood and ascitic fluid samples were cultured using the BACTEC 730 or 9240 system (Becton Dickinson). Identification and antimicrobial susceptibility testing of the isolates were performed using the MicroScan (Dade Behring) system. Aeromonas species were identified by MicroScan Negative Combo Panel 21 or 32, after Gram stain and oxidase test. The MicroScan criteria of drug susceptibility breakpoints for Aeromonas species were consistent with those of Clinical and Laboratory Standards Institute for Enterobacteriaceae species [19] .
Statistical analysis. Statistical analyses were performed using the x 2 test or a 2-tailed Fisher's exact test for binary variables and the Mann-Whitney U test for continuous, scaled variables. Continuous data were expressed as median and interquartile range. Variables with a P value !.1 in univariate analysis were included in a logistic regression model for multivariate analysis. was considered to be statistically significant. All tests P ! .05 were performed using SPSS software, version 12.0 (SPSS).
RESULTS
Demographic characteristics.
During the 10-year study period, 43 patients were admitted to the hospital for SBP due to Aeromonas species; these patients were matched with 81 control subjects. Twenty-two (51%) of the 43 patients in the group with Aeromonas infection and 54 (67%) of the 81 patients in the control group had definite cases of SBP. The median age in each group was 51 years (interquartile range, 43-59 years), and the male to female ratio in each group was 5:1. Of the 43 patients with SBP due to Aeromonas species, 40 (93%) were infected with Aeromonas hydrophila and 3 (7%) were infected with Aeromonas sorbia. Of the 81 control subjects, 38 (47%) were infected with Escherichia coli, 25 (31%) were infected with Klebsiella species, 12 (15%) were infected with Streptococcus species, and 6 (7%) were infected with other organisms. The group infected with other organisms included 3 patients infected with Acinetobacter species and 1 each infected with Citrobacter freundii, Proteus mirabilis, and Enterococcus faecalis. A statistically significant increase in the incidence of infection during the warm season (July-September) was observed in the group with SBP due to Aeromonas species (incidence increase to 63%) (figure 1) but not in the control group (incidence increase to 25%;
). In both groups, hepatitis B was the P ! .001 most common cause of cirrhosis. The frequency of hepatocellular carcinoma was significantly higher in the group with SBP due to Aeromonas species than in the control group (11 [26%] of 43 patients vs 4 [5%] of 81 patients;
). There were P ! .001 no other statistically significant differences between the groups with regard to comorbid diseases, CP class, and model for endstage liver disease score (table 1) .
Clinical manifestations and outcomes. Diarrheal episodes were significantly more frequent in the group with SBP due to Aeromonas species than in the control group (11 [26%] 
patients vs. 5 [6%] of 81 patients;
). None of the P p .002 patients used medicinal leeches or had skin or soft-tissue infections in either group. There were no statistically significant differences between the groups with regard to 3-day mortality, in-hospital mortality, and 30-day cumulative survival rates (table 2 and figure 2).
Initial antibiotics used and antibiotic susceptibility of Aeromonas isolates. 3 . We found that 90% of the isolated Aeromonas species were susceptible to cefotaxime, the most frequently prescribed antibiotic for the treatment of SBP in this study.
Prognostic factors for in-hospital mortality in the group with SBP due to Aeromonas species. The in-hospital mortality rate in the group with SBP due to Aeromonas species was 7%. Univariate analysis revealed that male sex, hepatic encephalopathy, septic shock, and renal function impairment were statistically significant predictors of mortality, whereas appropriateness of initial antibiotic therapy was not. Multivariate analysis revealed that septic shock was the only statistically significant risk factor (OR, 18.4; 95% CI, 1.86-640.62; P p ) (table 4) . .017
Subgroup analysis of patients with definite SBP cases. We performed a second analysis of patients with definite cases of SBP (16 patients with definite cases of SBP due to Aeromonas species and 18 patients with definite cases of SBP caused by other organisms). Seasonality was proven to not be a statistically significant risk factor for SBP due to Aeromonas species (8 [50%] of 16 patients with SBP due to Aeromonas species and 4 [22%] of 18 patients with SBP due to other organisms developed infection during the warm season;
), but di-P p .09 arrheal episodes were significantly more frequent in the group with SBP due to Aeromonas species (7 [44%] of 16 patients vs.
[0%] of 18 patients;
). P p .002
DISCUSSION
Aeromonas species, which are oxidase-positive, fermentative, gram-negative bacilli, are ubiquitous in fresh or brackish water and have been implicated in a variety of human diseases, including acute gastroenteritis, septicemia, skin and soft-tissue infections, hepatobiliary infection, pleuropulmonary infections, meningitis, and hemolytic uremic syndrome [20] . Aeromonas bacteremia is associated with cirrhosis and a high fatality rate [1] [2] [3] [4] . To date, however, except for in some anecdotal reports, SBP due to Aeromonas species in cirrhotic patients has not been evaluated. Therefore, we compared the clinical characteristics and outcomes of SBP due to Aeromonas species with those of SBP caused by other organisms. To our knowledge, this is the first case-control study to evaluate the characteristics and outcomes in patients with SBP due to Aeromonas species.
A previous report found that, of 34 patients with Aeromonas peritonitis (including continuous ambulatory peritoneal dialysis peritonitis and secondary peritonitis), 25 (74%) had cirrhosis and had a higher mortality rate than dud the other patients [6] . Moreover, of the 22 patients with primary peritonitis caused by Aeromonas species, 21 (95%) had cirrhosis and 20 (91%) had CP class C [21] . Although CP class is indicative of a link between SBP due to Aeromonas species and more-advanced cirrhosis, it has limitations in assessing liver function in patients with advanced cirrhosis. In addition, laboratory and clinical data obtained during acute disease are not representative of baseline characteristics. Therefore, we used the model for end-stage liver disease score in addition to CP class at baseline for evaluation and comparison. We found that these did not differ significantly between the group with SBP due to Aeromonas species and the control group.
Aeromonas species are the third most common gram-negative bacilli that cause bacteremia in cirrhotic patients in Taiwan and that cause SBP in cirrhotic patients in Korea [7, 8] . This prevalence is attributable to the high incidence of chronic liver diseases (hepatitis B and C) and cirrhosis, the eating of raw seafood or freshwater fish, and the ubiquitous presence of Aeromonas species in both countries [1, 8, 22] . Aeromonas species are regarded as causative organisms of diarrheal disease [23, 24] . In this study, we observed that 25% of patients with SBP due to Aeromonas species had diarrheal episodes before developing SBP. Because of the retrospective study design, we could not demonstrate a causative correlation (e.g., by performing stool cultures or enterotoxin analysis). In agreement with previous findings regarding Aeromonas-associated bacteremia and diarrhea, we found that SBP due to Aeromonas species showed extreme seasonality and was more prevalent during warm conditions [22, [23] [24] [25] [26] , likely because the optimal temperature for proliferation of this organism is 25ЊC-30ЊC [26] .
The in vitro antibiotic resistance of Aeromonas species suggests that ceftazidime, imipenem, and aztreonam should be the first-line choices for treatment [11] ; however, susceptibility patterns have been found to differ by location and clinical conditions [5, 11, 21, 22] . We found that 90% of Aeromonas isolates were susceptible to cefotaxime, thus indicating that first-line empirical therapy for SBP can be used to treat infection caused by these organisms. However, because resistance to multiple antibiotics in Aeromonas isolates can be mediated by several enzymes (chromosomal or plasmid mediated b-lactamases) because of selective pressure, meticulous attention and monitoring of resistance patterns are necessary [11, 27, 28] .
Our study has several limitations. First, we included cases of SBP proven only by blood culture with neurocytic ascites as probable cases. In subgroup analysis of patients with definite SBP, we could not determine the seasonal component for the group with SBP due to Aeromonas species. However, one-third of patients with culture-negative neutrocytic ascites had positive blood culture results [13] . Our patients with probable cases had no sign of local infection other than SBP. Therefore, we assure that both definite and probable cases could be included in this study without seriously compromising the results. Second, because it was an age-and sex-matched case-control study and not a randomized trial, an unknown risk factor may have been overlooked. We could not determine all of the potential sources of Aeromonas infection. In this study, none of the patients used medicinal leeches or had skin or soft-tissue infections. However, this does not indicate that the patients were not exposed to fresh or brackish water, another possible source of Aeromonas infection [3, 17] . Third, there may have been selection biases. The incidence rates of hepatitis B virus-associated chronic liver disease, cirrhosis, and hepatocellular carcinoma are high in the Republic of Korea, and the 2 study groups were selected from a single tertiary care institution specializing in transplantation. Thus, we may have selected patients with more-advanced cirrhosis. To our knowledge, the relationship between Aeromonas species and hepatitis B or hepatocellular carcinoma has not been determined.
In conclusion, cirrhotic patients with SBP who present with diarrhea during the warm season should be suspected to have SBP due to Aeromonas species. Compared with SBP caused by other organisms, SBP caused by Aeromonas species was not associated with more-advanced cirrhosis. Among the Aeromonas species, A. hydrophila was the most prevalent in patients with SBP; 90% of these organisms were susceptible to cefotaxime. The only independent risk factor for in-hospital mortality in the group with SBP caused by Aeromonas species was septic shock.
